Bryan Blette

Bryan Blette

Assistant Professor at Vanderbilt University Medical Center

Publications

You can also find my articles on my Google Scholar profile

Peer-Reviewed (* indicates co-first author)

  • Kahan, B., Li, F., Blette, B., Jairath, V., Copas, A., Harhay, M. Informative cluster size in cluster-randomised trials: A case study from the TRIGGER trial (accepted, Clinical Trials)
  • Blette, B., Moutchia, J., Al-Naamani, N., Ventetuolo, C., Cheng, C., Appleby, D., Urbanowicz, R., Fritz, J., Mazurek, J., Li, F., Kawut, S., Harhay, M. Multivariable risk scores as potential surrogate outcomes in pulmonary arterial hypertension trials (accepted, The Lancet Respiratory Medicine)
  • Schweickert, W., Jablonksi, J., Bayes, B., Chowdhury, M., Whitman, C., Tian, J., Blette, B., Tran, T., Halpern, S. Structured mobilization for critically ill patients: A pragmatic cluster-randomized trial (accepted, American Journal of Respiratory and Critical Care Medicine)
  • Blette, B.S.*, Granholm, A*, Li, F., Shankar-Hari, M., Lange, T., Munch, M.W., Møller, M.H., Perner, A. and Harhay, M.O. (2023). Causal Bayesian machine learning to assess treatment effect heterogeneity by dexamethasone dose for patients with COVID-19 and severe hypoxemia. Scientific Reports, 13(1), p.6570.
  • Harhay, M.O., Blette, B.S., Granholm, A., Moler, F.W., Zampieri, F.G., Goligher, E.C., Gardner, M.M., Topjian, A.A. and Yehya, N. (2022). A Bayesian interpretation of a pediatric cardiac arrest trial (THAPCA-OH). NEJM Evidence, p.EVIDoa2200196.
  • Spelke, M. B., Paul, R., Blette, B., Meltzer‐Brody, S., Schiller, C. E., Ncheka, J. M., Kasaro, M. P., Price, J. T., Stringer, J. S., Stringer, E.M. (2022). Interpersonal therapy vs. antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial. Journal of the International AIDS Society, 25(7), p.e25959.
  • Vielot, N., Becker-Dreps, S., Blette, B., Gonzalez, F., Toval-Ruiz, C., Gutierrez, L., Vilchez, S., Diez-Valcarce, M., Vinje, J., Becker-Dreps, S., Bucardo, F. (2022). First episodes of norovirus and sapovirus gastroenteritis protect against subsequent episodes in a Nicaraguan birth cohort. Epidemiology, 33(5), 650-653.
  • Bowman, N. M., Bucardo, F., Collins, M. H., Reyes, Y., Cuadra, E. C., Blette, B., …, Becker-Dreps, S. (2021). Clinical and epidemiological features of acute Zika virus infections in León, Nicaragua. The American Journal of Tropical Medicine and Hygiene, 105(4), 924-930.
  • Stringer, E. M., Martinez, E., Blette, B., Toval Ruiz, C. E., Boivin, M., Zepeda, O., …, Bucardo, F. (2021). Neurodevelopmental outcomes of children following in utero exposure to Zika in Nicaragua. Clinical Infectious Diseases, 72(5), e146-e153.
  • Vielot, N. A., González, F., Reyes, Y., Zepeda, O., Blette, B., Paniagua, M., …, Bucardo, F. (2021). Risk factors and clinical profile of Sapovirus-associated acute gastroenteritis in early childhood: A Nicaraguan birth cohort study. The Pediatric Infectious Disease Journal, 40(3), 220-226.
  • Gilbert, P.B., Blette, B.S., Shepherd, B.E. and Hudgens, M.G. (2020). Post-randomization biomarker effect modification analysis in an HIV vaccine clinical trial. Journal of Causal Inference, 8(1), pp.54-69.
  • Collins, M.H., Zepeda, O., Blette, B., Jadi, R., Morales, M., Pérez, R., Liou, G.J.A., Montoya-Cruz, M., Harris, E., Becker-Dreps, S. and de Silva, A.M. (2020). Serologic surveillance of maternal Zika infection in a prospective cohort in Leon, Nicaragua during the peak of the Zika epidemic. PloS One, 15(4), p.e0230692.
  • Neidich, S.D., Fong, Y., Li, S.S., Geraghty, D.E., Williamson, B.D., …, Blette, B., …, Tomaras, G. (2019). Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. Journal of Clinical Investigation, 129(11), pp.4838-4849.
  • Blette, B.S, Howard, A.G. and Frerichs, L.M. (2019). High school physical activity and nutrition policy: Summarizing changes over time using latent class analysis. American Journal of Preventive Medicine, 57(3), pp.e69-e76.
  • Becker-Dreps, S., Blette, B., Briceño, R., Alemán, J., Hudgens, M.G., Moreno, G., Ordoñez, A., Rocha, J., Weber, D.J. and Amaya, E. (2017). Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years following introduction of the 13-valent pneumococcal conjugate vaccine in a” 3+ 0” schedule. PloS One, 12(8), p.e0183348.

Under Review

  • Blette, B., Gilbert, P., Hudgens, M. Addressing confounding and continuous exposure measurement error using conditional score functions (under revision, Biometrics)
  • Kasaro, M., Blette, B., Paul, R., Meltzer-Brody, S., Mwanze, J., Spelke, M.B., Stringer, J., Stringer, E. Factors associated with severity of Edinburgh Postnatal Depression Screen (EPDS) and optimal cutoff of EPDS for diagnosing depression and anxiety among postpartum HIV positive women in Lusaka, Zambia (submitted)
  • Spelke, M.B., Okumu, E., Perry, N., Blette, B., Paul, R., Schiller, C., Ncheka, J.M., Kasaro, M., Price, J., Meltzer-Brody, S., Stringer, J., Stringer, E. Acceptability of a randomized trial of anti-depressant medication or interpersonal therapy for treatment of perinatal depression in HIV infected women (submitted)
  • Blette, B., Halpern, S., Li, F., Harhay, M. Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials (submitted, arXiv)
  • Max, R., Toval-Ruiz, C., Becker-Dreps, S., Gajewski, A., Martinez, E., Cross, K., Blette, B., …, Bucardo, F. Neurodevelopment in preschool children exposed and unexposed to Zika virus in utero (submitted)
  • Kahan, B., Blette, B., Harhay, M., Halpern, S., Jairath V., Copas, A., Li, F. Demystifying estimands in cluster-randomised trials (submitted, arXiv)
  • Hart, J., Summer, A., Ogunduyile, L., Lapite, F., Hong, D., Whitman, C., Blette, B., Harhay, M., Halpern, S. The accuracy and impact of patients’ expectations in severe chronic obstructive pulmonary disease: A longitudinal cohort study (submitted)
  • Huang, Y., Hejazi, N., Blette, B., …, Gilbert, P., Carpp, L. Evaluation of antibody assays as correlates of protection against symptomatic COVID-19 in the COVE mRNA-1273 vaccine efficacy trial utilizing principal surrogate and stochastic intervention vaccine efficacy frameworks (submitted)